These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9305372)

  • 21. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
    Gomperts ED; Darr F
    Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous immune globulin for multiple sclerosis.
    Tecnologica; 1995 May; ():10. PubMed ID: 10168292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
    Lo MS; Newburger JW
    Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
    Achiron A; Miron S
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies.
    Brannagan TH
    Neurology; 2002 Dec; 59(12 Suppl 6):S33-40. PubMed ID: 12499469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of the safety and tolerability of immune globulin intravenous (human) Sandoglobulin prepared in sterile water or 5% dextrose at various concentrations.
    Miller KB; Schenkein DP; Fogaren T
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):109-11. PubMed ID: 1509290
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
    Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
    J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
    [No Abstract]   [Full Text] [Related]  

  • 30. Rituximab and intravenous immune globulin for desensitization during renal transplantation.
    Vo AA; Lukovsky M; Toyoda M; Wang J; Reinsmoen NL; Lai CH; Peng A; Villicana R; Jordan SC
    N Engl J Med; 2008 Jul; 359(3):242-51. PubMed ID: 18635429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulins in MS: a panacea lacking approval?
    Hohlfeld R
    Int MS J; 2005 Apr; 12(1):1-2. PubMed ID: 15955271
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of multiple sclerosis: current opinion].
    Yamamura T
    No To Shinkei; 2001 Aug; 53(8):707-13. PubMed ID: 11577411
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous immune globulin.
    Med Lett Drugs Ther; 1992 Dec; 34(886):116-8. PubMed ID: 1465040
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action.
    Achiron A; Barak Y; Goren M; Gabbay U; Miron S; Rotstein Z; Noy S; Sarova-Pinhas I
    Clin Exp Immunol; 1996 May; 104 Suppl 1():67-70. PubMed ID: 8625547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of intravenous immune globulin treatment in neurologic disease.
    Brannagan TH; Nagle KJ; Lange DJ; Rowland LP
    Neurology; 1996 Sep; 47(3):674-7. PubMed ID: 8797463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran.
    Kalanie H; Gharagozli K; Hemmatie A; Ghorbanie M; Kalanie AR
    Eur Neurol; 2004; 52(4):202-6. PubMed ID: 15539773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis--the Israeli experience. MS Study Group.
    Achiron A; Rotstein Z; Barak Y; Sarova-Pinhas I
    Mult Scler; 1997 Apr; 3(2):142-4. PubMed ID: 9291169
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies.
    Sewell WA; Brennan VM; Donaghy M; Chapel HM
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):106-9. PubMed ID: 9221978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe thromboembolic complications associated with the administration of intravenous immunoglobulins.
    Gómez Pérez M; Hernández Segurado M; Bonilla Porras M; Bécares Martínez J
    Farm Hosp; 2012; 36(3):166-7. PubMed ID: 22118762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.